New Potential Therapeutic Target For Alzheimer’s Disease: Beta-CTF

New Potential Therapeutic Target For Alzheimer’s Disease: Beta-CTF
Researchers at New York University Langone Medical Center and the Nathan S. Kline Institute for Psychiatric Research (NKI) in New York recently discovered a potential therapeutic target for Alzheimer’s disease and provided more insight into the associated endosome dysfunction. The study was published in the journal Molecular Psychiatry and is entitled “Evidence that the rab5

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *